10,000 results
·
44ms
·
Sources: EU EUDAMED, US FDA
Inhibin alpha (QR088)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
Inhibin alpha (QR088)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
Inhibin alpha (QR088)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgA (QR050)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgA (QR050)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgA (QR050)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgA (QR050)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgA (QR050)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgA (QR050)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgA (QR050)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IDH1 R132H (QM002)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IDH1 R132H (QM002)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IDH1 R132H (QM002)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market